N onalcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease. In the United States, over 64 million people are projected to have NAFLD with estimated annual medical cost of $103 billion, which is about $1,613 per patient (Younossi et al., 2016). Liver biopsies determine the definitive diagnosis of liver diseases such as NAFLD, cirrhosis, Reducing Recovery Times in Outpatient Liver Biopsies
Role of the GI Nurse